The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. H...
Saved in:
Published in | International Journal of Obesity Vol. 42; no. 3; pp. 441 - 447 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.03.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background:
Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown.
Methods:
Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4–53.0 kg m
−2
) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content.
Results:
Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate,
r
=−0.46,
P
=0.001). Myocardial triglyceride content (β=−0.2,
P
=0.008), PCr/ATP (β=−0.22,
P
=0.04) and LV mass:volume ratio (β=−0.61,
P
=0.04) all independently predicted peak diastolic strain rate (model
R
2
0.36,
P
<0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling.
Conclusions:
Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity. |
---|---|
AbstractList | Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown.
Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m
) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content.
Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content (β=-0.2, P=0.008), PCr/ATP (β=-0.22, P=0.04) and LV mass:volume ratio (β=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R
0.36, P<0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling.
Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity. Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. Methods: Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m[sup.-2]) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. Results: Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content ([beta]=-0.2, P=0.008), PCr/ATP ([beta]=-0.22, P=0.04) and LV mass:volume ratio ([beta]=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R[sup.2] 0.36, P [less than] 0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. Conclusions: Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity. International Journal of Obesity (2018) 42, 441-447; doi: 10.1038/ijo.2017.239; published online 24 October 2017 Background:Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown.Methods:Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m-2 ) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content.Results:Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content (β=-0.2, P=0.008), PCr/ATP (β=-0.22, P=0.04) and LV mass:volume ratio (β=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R2 0.36, P<0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling.Conclusions:Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity. Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m[sup.-2]) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content ([beta]=-0.2, P=0.008), PCr/ATP ([beta]=-0.22, P=0.04) and LV mass:volume ratio ([beta]=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R[sup.2] 0.36, P [less than] 0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity. Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown.BACKGROUNDObesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown.Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m-2) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content.METHODSEighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4-53.0 kg m-2) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content.Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content (β=-0.2, P=0.008), PCr/ATP (β=-0.22, P=0.04) and LV mass:volume ratio (β=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R2 0.36, P<0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling.RESULTSIncreasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=-0.46, P=0.001). Myocardial triglyceride content (β=-0.2, P=0.008), PCr/ATP (β=-0.22, P=0.04) and LV mass:volume ratio (β=-0.61, P=0.04) all independently predicted peak diastolic strain rate (model R2 0.36, P<0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling.Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.CONCLUSIONSMyocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity. Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. Methods: Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4–53.0 kg m −2 ) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. Results: Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r =−0.46, P =0.001). Myocardial triglyceride content (β=−0.2, P =0.008), PCr/ATP (β=−0.22, P =0.04) and LV mass:volume ratio (β=−0.61, P =0.04) all independently predicted peak diastolic strain rate (model R 2 0.36, P <0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. Conclusions: Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity. |
Audience | Academic |
Author | Holloway, C J Neubauer, S Rayner, J J Peterzan, M A Lewis, A J M Francis, J M Rider, O J Banerjee, R |
Author_xml | – sequence: 1 givenname: J J surname: Rayner fullname: Rayner, J J organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford – sequence: 2 givenname: R surname: Banerjee fullname: Banerjee, R organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford – sequence: 3 givenname: C J surname: Holloway fullname: Holloway, C J organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford – sequence: 4 givenname: A J M surname: Lewis fullname: Lewis, A J M organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford – sequence: 5 givenname: M A surname: Peterzan fullname: Peterzan, M A organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford – sequence: 6 givenname: J M surname: Francis fullname: Francis, J M organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford – sequence: 7 givenname: S surname: Neubauer fullname: Neubauer, S organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford – sequence: 8 givenname: O J surname: Rider fullname: Rider, O J email: oliver.rider@gmail.com organization: Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28974742$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks9rHCEUx6WkNJu0t57LQKH00Nk64ziOl0II_QWBXtKzPB3ddXE0VSew_33d3aTJhhQPgn6-X_2-987QiQ9eI_S2wcsGk-Gz3YRlixu2bAl_gRZNx_qadpydoAUmmNWY9vQUnaW0wRhTittX6LQdOOtY1y7Q6nqtq6gdZHurKxV8jlbO2QZfBVNNOoMMzqoK_FilHGeV5wiuAulDnMDZbHWqcqhGCynvyXGbzOzV3sIWF6mTzdvX6KUBl_Sbu_0c_f729fryR3316_vPy4urWtFuyLUZjWRcA6FSdpIQowYDMPaEAVbjOCrNm563LRDVgyGK8LFE7yWn3DBCCTlHXw6-N7OcdOFLIHDiJtoJ4lYEsOL4xtu1WIVbQYcB0wEXg493BjH8mXXKYrJJaefA6zAn0fCOYc56tkPfP0E3YY6-xBOlIbxr6dCQB2oFTgvrTSjvqp2puKCk7TuCMS_U8hmqrFFPtrRFG1vOjwQfHgnWGlxep-D2rUvH4LvHFflXivsZKEB7AFQMKUVthLIZdj7lC9aJBovdoIkyaLtcTJRBK6JPT0T3vv_B6wOeCuZXOj6U6ln-L_nc5JE |
CitedBy_id | crossref_primary_10_1002_clc_23838 crossref_primary_10_1016_j_numecd_2020_07_011 crossref_primary_10_1007_s10557_022_07355_7 crossref_primary_10_1161_CIRCRESAHA_120_316101 crossref_primary_10_36660_abc_20200855 crossref_primary_10_3389_fphys_2021_785879 crossref_primary_10_1038_s41366_018_0263_2 crossref_primary_10_3390_medicina56100524 crossref_primary_10_1002_ejhf_1956 crossref_primary_10_2459_JCM_0000000000001397 crossref_primary_10_1152_physiol_00018_2023 crossref_primary_10_1002_ejhf_1617 crossref_primary_10_18087_cardio_2023_7_n2120 crossref_primary_10_20996_1819_6446_2020_02_09 crossref_primary_10_1038_s41467_023_44520_4 crossref_primary_10_1136_openhrt_2024_002711 crossref_primary_10_1002_mrm_28494 crossref_primary_10_1089_met_2018_0092 crossref_primary_10_1016_j_jchf_2020_04_016 crossref_primary_10_1016_j_pcad_2018_06_004 crossref_primary_10_1007_s11906_019_0939_6 crossref_primary_10_1016_j_hfc_2024_06_006 crossref_primary_10_1016_j_cardfail_2019_09_002 crossref_primary_10_1016_j_ijcard_2018_08_008 crossref_primary_10_1080_17446651_2018_1500894 crossref_primary_10_1016_j_ccl_2023_06_010 crossref_primary_10_3389_fendo_2023_1181452 crossref_primary_10_1093_ehjci_jeac270 crossref_primary_10_2147_JIR_S356038 crossref_primary_10_1016_j_soard_2021_09_009 crossref_primary_10_1113_EP091566 crossref_primary_10_3389_fendo_2024_1439691 crossref_primary_10_15275_rusomj_2022_0103 crossref_primary_10_1093_cvr_cvae139 crossref_primary_10_1093_eurjpc_zwad099 crossref_primary_10_1161_JAHA_122_029062 crossref_primary_10_1038_s41598_020_76497_1 crossref_primary_10_1002_nbm_5206 crossref_primary_10_1002_ejhf_1653 crossref_primary_10_3390_biomedicines10071519 crossref_primary_10_1111_echo_14838 crossref_primary_10_4093_dmj_2020_0221 crossref_primary_10_1007_s11695_025_07801_z crossref_primary_10_1016_j_gtc_2023_03_006 crossref_primary_10_1016_j_yexmp_2024_104895 crossref_primary_10_1161_CIRCULATIONAHA_121_054858 crossref_primary_10_1152_physrev_00030_2020 crossref_primary_10_1186_s12968_018_0513_4 crossref_primary_10_1093_eurheartj_ehab663 crossref_primary_10_1007_s40675_019_00160_z crossref_primary_10_1002_ajmg_a_63168 crossref_primary_10_1161_JAHA_123_030221 crossref_primary_10_1111_cob_12476 crossref_primary_10_1016_j_lfs_2023_122087 |
Cites_doi | 10.1136/heart.89.10.1152 10.1152/ajpheart.00499.2004 10.1016/j.amjcard.2006.01.063 10.1161/ATVBAHA.115.306561 10.1016/0002-9149(64)90014-1 10.1210/en.2003-1128 10.1210/mend.11.4.9907 10.1016/j.amjcard.2004.02.073 10.1136/hrt.2009.185009 10.1056/NEJMoa020245 10.1007/s10554-012-0174-6 10.1136/heartjnl-2012-302145 10.1152/ajpheart.00579.2006 10.1016/j.bbalip.2009.12.006 10.1074/jbc.275.19.14563 10.1038/ijo.2012.170 10.1093/eurjhf/hfq159 10.1002/mrm.23011 10.1016/0002-9343(76)90499-X 10.1016/j.jacc.2009.02.086 10.1161/CIRCULATIONAHA.111.069518 10.1161/CIRCHEARTFAILURE.115.002883 10.1002/bmb.2006.49403403168 10.1067/mje.2003.40 10.1080/152165401753311780 10.1161/01.CIR.0000127959.28627.F8 10.1016/S0002-9149(97)00505-5 10.1097/00000441-200104000-00003 10.1016/j.amjcard.2013.05.036 10.1016/j.jcmg.2009.10.012 10.1073/pnas.97.4.1784 10.3758/BRM.40.3.879 10.1016/j.jcmg.2014.12.019 10.1016/j.cardiores.2006.06.024 10.1016/j.jacc.2003.10.062 10.1073/pnas.0405499101 10.1016/j.pcad.2005.02.010 10.1152/ajpendo.00093.2009 10.1161/01.CIR.93.4.800 10.1186/1532-429X-11-9 10.1210/jc.2004-1963 10.1161/CIRCRESAHA.116.306842 10.1161/01.RES.0000089255.37804.72 10.1016/j.ijcard.2012.03.104 10.1056/NEJMra063052 10.1152/ajpheart.2000.278.4.H1345 10.1093/eurheartj/ehs341 10.1016/j.cardiores.2005.11.022 |
ContentType | Journal Article |
Copyright | The Author(s) 2018 COPYRIGHT 2018 Nature Publishing Group Copyright Nature Publishing Group Mar 2018 Copyright © 2018 The Author(s) 2018 The Author(s) |
Copyright_xml | – notice: The Author(s) 2018 – notice: COPYRIGHT 2018 Nature Publishing Group – notice: Copyright Nature Publishing Group Mar 2018 – notice: Copyright © 2018 The Author(s) 2018 The Author(s) |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7TK 7TS 7X2 7X7 7XB 88E 88G 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0K M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1038/ijo.2017.239 |
DatabaseName | SpringerOpen CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Physical Education Index Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Public Health Database (subscription) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Agricultural & Environmental Science Collection (subscription) ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Agricultural Science Database ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Physical Education Index Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Biological Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Agricultural Science Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health Diet & Clinical Nutrition Recreation & Sports |
DocumentTitleAlternate | Relative contribution of metabolic and structural abnormalities |
EISSN | 1476-5497 |
EndPage | 447 |
ExternalDocumentID | PMC5880580 A532643009 28974742 10_1038_ijo_2017_239 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: British Heart Foundation grantid: FS/16/70/32157 – fundername: British Heart Foundation grantid: FS/08/074/26233 – fundername: British Heart Foundation grantid: FS/14/54/30946 |
GroupedDBID | .55 .GJ 29J 36B 39C 5RE 7X2 7X7 8R4 8R5 A8Z ABDBF ABOCM ABUWG ACUHS ADBBV AFFNX AI. ALMA_UNASSIGNED_HOLDINGS ATCPS AZQEC B0M BAWUL BENPR BHPHI BPHCQ C6C DIK DWQXO EAD EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ HCIFZ IAO IHR ITC J5H M0K M1P M2M MVM NAO OK1 Q2X RNT RNTTT SV3 TUS VH1 WH7 X7M ZGI ZXP ~8M AAYXX CITATION --- -Q- ..I .L3 .XZ 0R~ 1CY 2FS 2WC 4.4 406 53G 5GY 70F 88E 8AO 8C1 8FE 8FH 8FI 8FJ AACDK AAHBH AANZL AASML AATNV AAWTL AAYZH ABAKF ABAWZ ABBRH ABCQX ABDBE ABFSG ABIVO ABJNI ABLJU ABRTQ ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACSTC ACZOJ ADHUB ADXHL AEFQL AEJRE AEMSY AENEX AEUYN AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV AMYLF APEBS ATHPR AXYYD AYFIA BBNVY BKKNO BVXVI CCPQU CGR CS3 CUY CVF DNIVK DPUIP DU5 E3Z EBLON ECM EE. EIF EIOEI EJD FDQFY FERAY FIGPU FIZPM FSGXE HMCUK HZ~ IHW INH INR IPY IWAJR JSO JZLTJ KQ8 L7B M7P NPM NQJWS O9- OVD P2P P6G PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PSYQQ RNS ROL SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG UKHRP ~KM 3V. 7T2 7TK 7TS 7XB 8FK C1K K9. LK8 PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c548t-fdfb79ea35bb4b33fc8faad637a0cdddce916922a3c6af3c39d0176b959f73533 |
IEDL.DBID | C6C |
ISSN | 0307-0565 1476-5497 |
IngestDate | Thu Aug 21 18:14:21 EDT 2025 Fri Jul 11 10:50:18 EDT 2025 Wed Jul 16 16:06:21 EDT 2025 Tue Jun 17 21:47:05 EDT 2025 Tue Jun 10 20:50:11 EDT 2025 Thu May 22 21:23:18 EDT 2025 Mon Jul 21 06:04:04 EDT 2025 Tue Jul 01 03:01:58 EDT 2025 Thu Apr 24 22:57:14 EDT 2025 Fri Feb 21 02:39:11 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c548t-fdfb79ea35bb4b33fc8faad637a0cdddce916922a3c6af3c39d0176b959f73533 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.nature.com/articles/ijo.2017.239 |
PMID | 28974742 |
PQID | 2019425813 |
PQPubID | 38864 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5880580 proquest_miscellaneous_1947097670 proquest_journals_2019425813 gale_infotracmisc_A532643009 gale_infotracacademiconefile_A532643009 gale_healthsolutions_A532643009 pubmed_primary_28974742 crossref_citationtrail_10_1038_ijo_2017_239 crossref_primary_10_1038_ijo_2017_239 springer_journals_10_1038_ijo_2017_239 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-03-01 |
PublicationDateYYYYMMDD | 2018-03-01 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | International Journal of Obesity |
PublicationTitleAbbrev | Int J Obes |
PublicationTitleAlternate | Int J Obes (Lond) |
PublicationYear | 2018 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Neubauer (CR26) 2007; 356 Rajapurohitam, Gan, Kirshenbaum, Karmazyn (CR42) 2003; 93 Zeidan, Javadov, Karmazyn (CR45) 2006; 72 Rider, Francis, Tyler, Byrne, Clarke, Neubauer (CR51) 2012; 29 Zeidan, Erbel, Barkhausen, Hunold, Bartel, Buck (CR19) 2003; 16 Rider, Francis, Ali, Holloway, Pegg, Robson (CR11) 2012; 125 Kossaify, Nicolas (CR13) 2013; 7 Abe, Ono, Kawamura, Wada, Kita, Shimatsu (CR44) 2007; 292 Peterson, Waggoner, Schechtman, Meyer, Gropler, Barzilai (CR9) 2004; 43 Hue, Taegtmeyer (CR29) 2009; 297 Rider, Lewandowski, Nethononda, Petersen, Francis, Pitcher (CR16) 2013; 34 Peterson, Herrero, Schechtman, Racette, Waggoner, Kisrieva-Ware (CR31) 2004; 109 Banks, Davis, Bates, Myers (CR46) 2000; 275 Rider, Petersen, Francis, Ali, Hudsmith, Robinson (CR39) 2011; 97 Veech (CR27) 2006; 34 Kenchaiah, Evans, Levy, Wilson, Benjamin, Larson (CR1) 2002; 347 Virtue, Vidal-Puig (CR32) 2010; 1801 Adamopoulos, Meyer, Desai, Karatzidou, Ovalle, White (CR22) 2011; 13 Madani, De Girolamo, Munoz, Li, Sweeney (CR41) 2006; 69 Rider, Francis, Ali, Petersen, Robinson, Robson (CR10) 2009; 54 Owan, Redfield (CR3) 2005; 47 Rial, Robson, Neubauer, Schneider (CR21) 2011; 66 Nelson, Victor, Szczepaniak, Simha, Garg, Szczepaniak (CR33) 2013; 112 Banerjee, Rial, Holloway, Lewandowski, Robson, Osuchukwu (CR17) 2015; 8 Cittadini, Stromer, Katz, Clark, Moses, Morgan (CR48) 1996; 93 Powell, Redfield, Bybee, Freeman, Rihal (CR4) 2006; 98 Holloway, Dass, Suttie, Rider, Cox, Cochlin (CR24) 2012; 98 Turkbey, McClelland, Kronmal, Burke, Bild, Tracy (CR37) 2010; 3 Ghilardi, Skoda (CR47) 1997; 11 Zhou, Grayburn, Karim, Shimabukuro, Higa, Baetens (CR50) 2000; 97 Utz, Engeli, Haufe, Kast, Bohnke, Haas (CR52) 2012; 167 Veech, Chance, Kashiwaya, Lardy, Cahill (CR28) 2001; 51 Rider, Francis, Tyler, Byrne, Clarke, Neubauer (CR15) 2013; 29 Tajmir, Ceddia, Li, Coe, Sweeney (CR43) 2004; 145 Lee, Naseem, Duplomb, Park, Garry, Richardson (CR49) 2004; 101 Purdham, Zou, Rajapurohitam, Karmazyn (CR40) 2004; 287 Alpert, Terry, Mulekar, Cohen, Massey, Fan (CR2) 1997; 80 Preacher, Hayes (CR25) 2008; 40 Rider, Banerjee, Rayner, Shah, Murthy, Robson (CR20) 2016; 36 Rider, Cox, Tyler, Clarke, Neubauer (CR18) 2013; 37 Alpert (CR35) 2001; 321 Kaltman, Goldring (CR7) 1976; 60 Eaton, Pettinger, Rossouw, Martin, Foraker, Quddus (CR14) 2016; 9 Alexander (CR6) 1964; 14 Perego, Pizzocri, Corradi, Maisano, Paganelli, Fiorina (CR38) 2005; 90 Rider, Francis, Ali, Byrne, Clarke, Neubauer (CR5) 2009; 11 Alexander (CR36) 1993; 2 Korvald, Elvenes, Myrmel (CR30) 2000; 278 Otto, Belohlavek, Khandheria, Gilman, Svatikova, Somers (CR8) 2004; 93 Pascual, Pascual, Soria, Vicente, Hernandez, Tebar (CR12) 2003; 89 Schulze, Drosatos, Goldberg (CR34) 2016; 118 Levelt, Rodgers, Clarke, Mahmod, Ariga, Francis (CR23) 2015; 65 JK Alexander (BFijo2017239_CR36) 1993; 2 L Hue (BFijo2017239_CR29) 2009; 297 JK Alexander (BFijo2017239_CR6) 1964; 14 S Kenchaiah (BFijo2017239_CR1) 2002; 347 BD Powell (BFijo2017239_CR4) 2006; 98 OJ Rider (BFijo2017239_CR11) 2012; 125 E Levelt (BFijo2017239_CR23) 2015; 65 RL Veech (BFijo2017239_CR27) 2006; 34 Y Abe (BFijo2017239_CR44) 2007; 292 Y Lee (BFijo2017239_CR49) 2004; 101 AJ Kaltman (BFijo2017239_CR7) 1976; 60 V Rajapurohitam (BFijo2017239_CR42) 2003; 93 LR Peterson (BFijo2017239_CR9) 2004; 43 AS Banks (BFijo2017239_CR46) 2000; 275 N Ghilardi (BFijo2017239_CR47) 1997; 11 MA Alpert (BFijo2017239_CR2) 1997; 80 A Kossaify (BFijo2017239_CR13) 2013; 7 EB Turkbey (BFijo2017239_CR37) 2010; 3 ME Otto (BFijo2017239_CR8) 2004; 93 S Madani (BFijo2017239_CR41) 2006; 69 TE Owan (BFijo2017239_CR3) 2005; 47 KJ Preacher (BFijo2017239_CR25) 2008; 40 OJ Rider (BFijo2017239_CR16) 2013; 34 R Banerjee (BFijo2017239_CR17) 2015; 8 OJ Rider (BFijo2017239_CR5) 2009; 11 S Virtue (BFijo2017239_CR32) 2010; 1801 Z Zeidan (BFijo2017239_CR19) 2003; 16 DM Purdham (BFijo2017239_CR40) 2004; 287 W Utz (BFijo2017239_CR52) 2012; 167 A Zeidan (BFijo2017239_CR45) 2006; 72 A Cittadini (BFijo2017239_CR48) 1996; 93 OJ Rider (BFijo2017239_CR51) 2012; 29 L Perego (BFijo2017239_CR38) 2005; 90 OJ Rider (BFijo2017239_CR20) 2016; 36 PC Schulze (BFijo2017239_CR34) 2016; 118 CB Eaton (BFijo2017239_CR14) 2016; 9 OJ Rider (BFijo2017239_CR10) 2009; 54 OJ Rider (BFijo2017239_CR15) 2013; 29 B Rial (BFijo2017239_CR21) 2011; 66 YT Zhou (BFijo2017239_CR50) 2000; 97 M Pascual (BFijo2017239_CR12) 2003; 89 LR Peterson (BFijo2017239_CR31) 2004; 109 MD Nelson (BFijo2017239_CR33) 2013; 112 OJ Rider (BFijo2017239_CR39) 2011; 97 CJ Holloway (BFijo2017239_CR24) 2012; 98 OJ Rider (BFijo2017239_CR18) 2013; 37 MA Alpert (BFijo2017239_CR35) 2001; 321 S Neubauer (BFijo2017239_CR26) 2007; 356 RL Veech (BFijo2017239_CR28) 2001; 51 C Adamopoulos (BFijo2017239_CR22) 2011; 13 P Tajmir (BFijo2017239_CR43) 2004; 145 C Korvald (BFijo2017239_CR30) 2000; 278 31227797 - Int J Obes (Lond). 2019 Aug;43(8):1652. doi: 10.1038/s41366-019-0404-2. |
References_xml | – volume: 89 start-page: 1152 year: 2003 end-page: 1156 ident: CR12 article-title: Effects of isolated obesity on systolic and diastolic left ventricular function publication-title: Heart doi: 10.1136/heart.89.10.1152 – volume: 287 start-page: H2877 year: 2004 end-page: H2884 ident: CR40 article-title: Rat heart is a site of leptin production and action publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00499.2004 – volume: 98 start-page: 116 year: 2006 end-page: 120 ident: CR4 article-title: Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2006.01.063 – volume: 36 start-page: 198 year: 2016 end-page: 203 ident: CR20 article-title: Investigating a liver fat: arterial stiffening pathway in adult and childhood obesity publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.115.306561 – volume: 14 start-page: 860 year: 1964 end-page: 865 ident: CR6 article-title: Obesity and cardiac performance publication-title: Am J Cardiol doi: 10.1016/0002-9149(64)90014-1 – volume: 145 start-page: 1550 year: 2004 end-page: 1555 ident: CR43 article-title: Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways publication-title: Endocrinology doi: 10.1210/en.2003-1128 – volume: 11 start-page: 393 year: 1997 end-page: 399 ident: CR47 article-title: The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line publication-title: Mol Endocrinol doi: 10.1210/mend.11.4.9907 – volume: 93 start-page: 1569 year: 2004 end-page: 1572 ident: CR8 article-title: Comparison of right and left ventricular function in obese and nonobese men publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2004.02.073 – volume: 97 start-page: 203 year: 2011 end-page: 208 ident: CR39 article-title: Ventricular hypertrophy and cavity dilatation in relation to body mass index in females with uncomplicated obesity publication-title: Heart doi: 10.1136/hrt.2009.185009 – volume: 347 start-page: 305 year: 2002 end-page: 313 ident: CR1 article-title: Obesity and the risk of heart failure publication-title: N Engl J Med doi: 10.1056/NEJMoa020245 – volume: 29 start-page: 1043 year: 2012 end-page: 1050 ident: CR51 article-title: Effects of weight loss on myocardial energetics and diastolic function in obesity publication-title: Int J Cardiovasc Imaging doi: 10.1007/s10554-012-0174-6 – volume: 98 start-page: 1083 year: 2012 end-page: 1090 ident: CR24 article-title: Exercise training in dilated cardiomyopathy improves rest and stress cardiac function without changes in cardiac high energy phosphate metabolism publication-title: Heart doi: 10.1136/heartjnl-2012-302145 – volume: 292 start-page: H2387 year: 2007 end-page: H2396 ident: CR44 article-title: Leptin induces elongation of cardiac myocyte and causes eccentric left ventricular dilatation with compensation publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00579.2006 – volume: 1801 start-page: 338 year: 2010 end-page: 349 ident: CR32 article-title: Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective publication-title: Biochim Biophys Acta doi: 10.1016/j.bbalip.2009.12.006 – volume: 275 start-page: 14563 year: 2000 end-page: 14572 ident: CR46 article-title: Activation of downstream signals by the long form of the leptin receptor publication-title: J Biol Chem doi: 10.1074/jbc.275.19.14563 – volume: 37 start-page: 972 year: 2013 end-page: 979 ident: CR18 article-title: Myocardial substrate metabolism in obesity publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2012.170 – volume: 13 start-page: 200 year: 2011 end-page: 206 ident: CR22 article-title: Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study publication-title: Eur J Heart Fail doi: 10.1093/eurjhf/hfq159 – volume: 66 start-page: 619 year: 2011 end-page: 624 ident: CR21 article-title: Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla publication-title: Magn Reson Med doi: 10.1002/mrm.23011 – volume: 60 start-page: 645 year: 1976 end-page: 653 ident: CR7 article-title: Role of circulatory congestion in the cardiorespiratory failure of obesity publication-title: Am J Med doi: 10.1016/0002-9343(76)90499-X – volume: 54 start-page: 718 year: 2009 end-page: 726 ident: CR10 article-title: Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.02.086 – volume: 125 start-page: 1511 year: 2012 end-page: 1519 ident: CR11 article-title: Effects of catecholamine stress on diastolic function and myocardial energetics in obesity publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.069518 – volume: 9 start-page: pii: e002883 year: 2016 ident: CR14 article-title: Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.115.002883 – volume: 34 start-page: 168 year: 2006 end-page: 179 ident: CR27 article-title: The determination of the redox states and phosphorylation potential in living tissues and their relationship to metabolic control of disease phenotypes publication-title: Biochem Mol Biol Educ doi: 10.1002/bmb.2006.49403403168 – volume: 16 start-page: 29 year: 2003 end-page: 37 ident: CR19 article-title: Analysis of global systolic and diastolic left ventricular performance using volume-time curves by real-time three-dimensional echocardiography publication-title: J Am Soc Echocardiogr doi: 10.1067/mje.2003.40 – volume: 29 start-page: 1043 year: 2013 end-page: 1050 ident: CR15 article-title: Effects of weight loss on myocardial energetics and diastolic function in obesity publication-title: Int J Cardiovasc Imaging doi: 10.1007/s10554-012-0174-6 – volume: 51 start-page: 241 year: 2001 end-page: 247 ident: CR28 article-title: Ketone bodies, potential therapeutic uses publication-title: IUBMB Life doi: 10.1080/152165401753311780 – volume: 2 start-page: 317 year: 1993 end-page: 321 ident: CR36 article-title: Obesity and the heart publication-title: Heart Dis Stroke – volume: 109 start-page: 2191 year: 2004 end-page: 2196 ident: CR31 article-title: Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women publication-title: Circulation doi: 10.1161/01.CIR.0000127959.28627.F8 – volume: 80 start-page: 736 year: 1997 end-page: 740 ident: CR2 article-title: Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss publication-title: Am J Cardiol doi: 10.1016/S0002-9149(97)00505-5 – volume: 321 start-page: 225 year: 2001 end-page: 236 ident: CR35 article-title: Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome publication-title: Am J Med Sci doi: 10.1097/00000441-200104000-00003 – volume: 112 start-page: 1019 year: 2013 end-page: 1024 ident: CR33 article-title: Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2013.05.036 – volume: 3 start-page: 266 year: 2010 end-page: 274 ident: CR37 article-title: The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA) publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2009.10.012 – volume: 97 start-page: 1784 year: 2000 end-page: 1789 ident: CR50 article-title: Lipotoxic heart disease in obese rats: implications for human obesity publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.97.4.1784 – volume: 40 start-page: 879 year: 2008 end-page: 891 ident: CR25 article-title: Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models publication-title: Behav Res Methods doi: 10.3758/BRM.40.3.879 – volume: 8 start-page: 1468 year: 2015 end-page: 1470 ident: CR17 article-title: Evidence of a direct effect of myocardial steatosis on LV hypertrophy and diastolic dysfunction in adult and adolescent obesity publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2014.12.019 – volume: 72 start-page: 101 year: 2006 end-page: 111 ident: CR45 article-title: Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2006.06.024 – volume: 43 start-page: 1399 year: 2004 end-page: 1404 ident: CR9 article-title: Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2003.10.062 – volume: 101 start-page: 13624 year: 2004 end-page: 13629 ident: CR49 article-title: Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0405499101 – volume: 47 start-page: 320 year: 2005 end-page: 332 ident: CR3 article-title: Epidemiology of diastolic heart failure publication-title: Prog Cardiovasc Dis doi: 10.1016/j.pcad.2005.02.010 – volume: 297 start-page: E578 year: 2009 end-page: E591 ident: CR29 article-title: The Randle cycle revisited: a new head for an old hat publication-title: Am J Physiol-Endocrinol Metab doi: 10.1152/ajpendo.00093.2009 – volume: 93 start-page: 800 year: 1996 end-page: 809 ident: CR48 article-title: Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined and evaluation publication-title: Circulation doi: 10.1161/01.CIR.93.4.800 – volume: 11 start-page: 9 year: 2009 ident: CR5 article-title: Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study publication-title: J Cardiovasc Magn Reson doi: 10.1186/1532-429X-11-9 – volume: 90 start-page: 4087 year: 2005 end-page: 4093 ident: CR38 article-title: Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-1963 – volume: 118 start-page: 1736 year: 2016 end-page: 1751 ident: CR34 article-title: Lipid use and misuse by the heart publication-title: Circ Res doi: 10.1161/CIRCRESAHA.116.306842 – volume: 7 start-page: 43 year: 2013 end-page: 50 ident: CR13 article-title: Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography publication-title: Clin Med Insights Cardiol – volume: 65 start-page: 44 year: 2015 end-page: 52 ident: CR23 article-title: Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus publication-title: Eur Heart J – volume: 93 start-page: 277 year: 2003 end-page: 279 ident: CR42 article-title: The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes publication-title: Circ Res doi: 10.1161/01.RES.0000089255.37804.72 – volume: 167 start-page: 905 year: 2012 end-page: 909 ident: CR52 article-title: Moderate dietary weight loss reduces myocardial steatosis in obese and overweight women publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2012.03.104 – volume: 356 start-page: 1140 year: 2007 end-page: 1151 ident: CR26 article-title: The failing heart—an engine out of fuel publication-title: N Engl J Med doi: 10.1056/NEJMra063052 – volume: 278 start-page: H1345 year: 2000 end-page: H1351 ident: CR30 article-title: Myocardial substrate metabolism influences left ventricular energetics publication-title: Am J Physiol-Heart Circulat Physiol doi: 10.1152/ajpheart.2000.278.4.H1345 – volume: 34 start-page: 292 year: 2013 end-page: 299 ident: CR16 article-title: Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs341 – volume: 69 start-page: 716 year: 2006 end-page: 725 ident: CR41 article-title: Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2005.11.022 – volume: 167 start-page: 905 year: 2012 ident: BFijo2017239_CR52 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2012.03.104 – volume: 72 start-page: 101 year: 2006 ident: BFijo2017239_CR45 publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2006.06.024 – volume: 3 start-page: 266 year: 2010 ident: BFijo2017239_CR37 publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2009.10.012 – volume: 1801 start-page: 338 year: 2010 ident: BFijo2017239_CR32 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbalip.2009.12.006 – volume: 109 start-page: 2191 year: 2004 ident: BFijo2017239_CR31 publication-title: Circulation doi: 10.1161/01.CIR.0000127959.28627.F8 – volume: 321 start-page: 225 year: 2001 ident: BFijo2017239_CR35 publication-title: Am J Med Sci doi: 10.1097/00000441-200104000-00003 – volume: 29 start-page: 1043 year: 2012 ident: BFijo2017239_CR51 publication-title: Int J Cardiovasc Imaging doi: 10.1007/s10554-012-0174-6 – volume: 13 start-page: 200 year: 2011 ident: BFijo2017239_CR22 publication-title: Eur J Heart Fail doi: 10.1093/eurjhf/hfq159 – volume: 90 start-page: 4087 year: 2005 ident: BFijo2017239_CR38 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-1963 – volume: 11 start-page: 393 year: 1997 ident: BFijo2017239_CR47 publication-title: Mol Endocrinol doi: 10.1210/mend.11.4.9907 – volume: 145 start-page: 1550 year: 2004 ident: BFijo2017239_CR43 publication-title: Endocrinology doi: 10.1210/en.2003-1128 – volume: 43 start-page: 1399 year: 2004 ident: BFijo2017239_CR9 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2003.10.062 – volume: 7 start-page: 43 year: 2013 ident: BFijo2017239_CR13 publication-title: Clin Med Insights Cardiol – volume: 47 start-page: 320 year: 2005 ident: BFijo2017239_CR3 publication-title: Prog Cardiovasc Dis doi: 10.1016/j.pcad.2005.02.010 – volume: 101 start-page: 13624 year: 2004 ident: BFijo2017239_CR49 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0405499101 – volume: 34 start-page: 292 year: 2013 ident: BFijo2017239_CR16 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs341 – volume: 118 start-page: 1736 year: 2016 ident: BFijo2017239_CR34 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.116.306842 – volume: 89 start-page: 1152 year: 2003 ident: BFijo2017239_CR12 publication-title: Heart doi: 10.1136/heart.89.10.1152 – volume: 69 start-page: 716 year: 2006 ident: BFijo2017239_CR41 publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2005.11.022 – volume: 347 start-page: 305 year: 2002 ident: BFijo2017239_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMoa020245 – volume: 98 start-page: 116 year: 2006 ident: BFijo2017239_CR4 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2006.01.063 – volume: 66 start-page: 619 year: 2011 ident: BFijo2017239_CR21 publication-title: Magn Reson Med doi: 10.1002/mrm.23011 – volume: 34 start-page: 168 year: 2006 ident: BFijo2017239_CR27 publication-title: Biochem Mol Biol Educ doi: 10.1002/bmb.2006.49403403168 – volume: 37 start-page: 972 year: 2013 ident: BFijo2017239_CR18 publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2012.170 – volume: 275 start-page: 14563 year: 2000 ident: BFijo2017239_CR46 publication-title: J Biol Chem doi: 10.1074/jbc.275.19.14563 – volume: 297 start-page: E578 year: 2009 ident: BFijo2017239_CR29 publication-title: Am J Physiol-Endocrinol Metab doi: 10.1152/ajpendo.00093.2009 – volume: 112 start-page: 1019 year: 2013 ident: BFijo2017239_CR33 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2013.05.036 – volume: 97 start-page: 1784 year: 2000 ident: BFijo2017239_CR50 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.97.4.1784 – volume: 278 start-page: H1345 year: 2000 ident: BFijo2017239_CR30 publication-title: Am J Physiol-Heart Circulat Physiol doi: 10.1152/ajpheart.2000.278.4.H1345 – volume: 292 start-page: H2387 year: 2007 ident: BFijo2017239_CR44 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00579.2006 – volume: 16 start-page: 29 year: 2003 ident: BFijo2017239_CR19 publication-title: J Am Soc Echocardiogr doi: 10.1067/mje.2003.40 – volume: 93 start-page: 1569 year: 2004 ident: BFijo2017239_CR8 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2004.02.073 – volume: 29 start-page: 1043 year: 2013 ident: BFijo2017239_CR15 publication-title: Int J Cardiovasc Imaging doi: 10.1007/s10554-012-0174-6 – volume: 125 start-page: 1511 year: 2012 ident: BFijo2017239_CR11 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.069518 – volume: 8 start-page: 1468 year: 2015 ident: BFijo2017239_CR17 publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2014.12.019 – volume: 65 start-page: 44 year: 2015 ident: BFijo2017239_CR23 publication-title: Eur Heart J – volume: 60 start-page: 645 year: 1976 ident: BFijo2017239_CR7 publication-title: Am J Med doi: 10.1016/0002-9343(76)90499-X – volume: 54 start-page: 718 year: 2009 ident: BFijo2017239_CR10 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.02.086 – volume: 2 start-page: 317 year: 1993 ident: BFijo2017239_CR36 publication-title: Heart Dis Stroke – volume: 9 start-page: pii: e002883 year: 2016 ident: BFijo2017239_CR14 publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.115.002883 – volume: 36 start-page: 198 year: 2016 ident: BFijo2017239_CR20 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.115.306561 – volume: 80 start-page: 736 year: 1997 ident: BFijo2017239_CR2 publication-title: Am J Cardiol doi: 10.1016/S0002-9149(97)00505-5 – volume: 40 start-page: 879 year: 2008 ident: BFijo2017239_CR25 publication-title: Behav Res Methods doi: 10.3758/BRM.40.3.879 – volume: 14 start-page: 860 year: 1964 ident: BFijo2017239_CR6 publication-title: Am J Cardiol doi: 10.1016/0002-9149(64)90014-1 – volume: 93 start-page: 800 year: 1996 ident: BFijo2017239_CR48 publication-title: Circulation doi: 10.1161/01.CIR.93.4.800 – volume: 287 start-page: H2877 year: 2004 ident: BFijo2017239_CR40 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00499.2004 – volume: 93 start-page: 277 year: 2003 ident: BFijo2017239_CR42 publication-title: Circ Res doi: 10.1161/01.RES.0000089255.37804.72 – volume: 51 start-page: 241 year: 2001 ident: BFijo2017239_CR28 publication-title: IUBMB Life doi: 10.1080/152165401753311780 – volume: 97 start-page: 203 year: 2011 ident: BFijo2017239_CR39 publication-title: Heart doi: 10.1136/hrt.2009.185009 – volume: 356 start-page: 1140 year: 2007 ident: BFijo2017239_CR26 publication-title: N Engl J Med doi: 10.1056/NEJMra063052 – volume: 11 start-page: 9 year: 2009 ident: BFijo2017239_CR5 publication-title: J Cardiovasc Magn Reson doi: 10.1186/1532-429X-11-9 – volume: 98 start-page: 1083 year: 2012 ident: BFijo2017239_CR24 publication-title: Heart doi: 10.1136/heartjnl-2012-302145 – reference: 31227797 - Int J Obes (Lond). 2019 Aug;43(8):1652. doi: 10.1038/s41366-019-0404-2. |
SSID | ssj0005502 ssj0033214 |
Score | 2.481178 |
Snippet | Background:
Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is... Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined... Background: Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is... Background:Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is... |
SourceID | pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 441 |
SubjectTerms | 59/57 692/499 692/699/75 Abnormalities Adult Body mass Body Mass Index Cardiovascular diseases Cohort Studies Diastole (Cardiac cycle) Diastole - physiology Epidemiology Female Health aspects Health Promotion and Disease Prevention Health risks Heart diseases Heart function Humans Hypertrophy Internal Medicine Intra-Abdominal Fat - diagnostic imaging Intra-Abdominal Fat - physiopathology Magnetic Resonance Imaging Magnetic resonance spectroscopy Male Medicine Medicine & Public Health Metabolic Diseases Metabolism Obesity Obesity - diagnostic imaging Obesity - epidemiology Obesity - physiopathology Original original-article Physiological aspects Public Health Risk analysis Risk factors Steatosis Strain rate Triglycerides Triglycerides - blood Ventricle Ventricular Dysfunction, Left - diagnostic imaging Ventricular Dysfunction, Left - physiopathology |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgLguXRQAEjQTmgQDaO4_iEKqCqkNoTlfZmOX6URdukKAGJf8-M42SbFXDblWe9juezZyYef0PIKzAblhkIcqThOi2ckKn2SwaftKsy6TMfagOenpUn58WXFV_FF25dTKsc98SwUdvW4DtyCNIh3M55tWQfrn6kWDUKT1djCY2b5BZSlyGqxUpsUzx4NnFJMazIM7IigtXnMQs-Y9X79Xe8BrgU73KsGX7NPu3u0tfM1G4K5c45ajBPx_fI3ehX0qMBCPfJDdcsSPJp7Xp6SCP554aejdz7C3L7NJ6qL8hi6zuCcKh73j0gF4AgOlx1-eVoSGmPtbFo6-ml6wE-m7WhurF0YKFFBg-q6wbd4E1gaqV9SwGA4GCipP3doRkNXayhl6EmwUNyfvz568eTNJZlSA2EN33qra-FdJrxui5qxrypvNa2ZEJnxlqYEnA5ZZ5rZkrtmWHSwtyWNejHCwbu5SOy17SN2ye0qiAarXO59LUspLXQi9Qi1yW3woDrmZC3ozKUiZzlWDpjo8LZOasUqE6h6hSoLiGvJ-mrgavjH3IvUK9quGk6LXF1xMGXLRh4nQl5EyRwkcP_GR3vKsCokS5rJnkwk4TFaebNI3ZU3Bw6tYVyQl5OzfhLTHhrXPuzUyAhMnAVRZaQxwPUpmeCGBmCwCJPiJiBcBJAyvB5S7P-FqjDOWzXvII-D0e4bof1t6l68v_xPyV34Es15OQdkD0Am3sGTlpfPw8r8Q9FCjsp priority: 102 providerName: ProQuest |
Title | The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity |
URI | https://link.springer.com/article/10.1038/ijo.2017.239 https://www.ncbi.nlm.nih.gov/pubmed/28974742 https://www.proquest.com/docview/2019425813 https://www.proquest.com/docview/1947097670 https://pubmed.ncbi.nlm.nih.gov/PMC5880580 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_uA0QQ0fpVPdcIej549bpN0ySPu-sth3CLiAf7VtKk0T3WrrBV8L93kn6sXRR8aQuZzqbJJDOzmfkNwCtUG4ZqdHKkZipKSy4jZccUn1QpYmlj62sDXi2yy-v0w5ItD-Csy4XxQfse0tJv01102PnqxmXqjfm7hMpDOHag7c7VmmWzXUAHi3vkKOrq73QYiKjjWRvzHlMxYDXQRvt78h9KaT9gcu_U1Cuj-T2421qRZNL0-z4clFUA4ftVWZNT0kJ9rsmiQ9oP4NZVe4YewJ3mnzrSJCAFEOwsR3zZVz3fPoAvKD-kSXT5WRIf0N5WxiIbS76VNQqP46IqQxoMWoffQVRROSN47XFaSb0hKH5oXjpK82vrlKhnsUIuTUWCh3A9v_g8u4zaogyRRuemjqyxBZeloqwo0oJSq4VVymSUq1gbg0OEBqdMEkV1pizVVBoc66yQTFpO0bh8BEfVpiqfABECfdEikWNbyFQag1yk4onKmOEaDc8Q3naTk-sWsdwVzljn_uScihynMndTmeNUhvC6p_7eIHX8g-6Fm-e8yTPtF3g-YWjJphRtzhDeeAq3xPH3tGozFbDXDixrQHkyoMSlqYfNnSzl7dawdf2QuFGKMX7fy77ZvenC3apy82ObIwWP0VDkcQiPG9Hrvwk9ZHQB0yQEPhDKnsABhg9bqtVXDxzOcLNmAnmeduK769bfhurp_xI-g9v4KJrYvBM4QrErn6OxVhcjOORLjlcxG4_geDKfThd4n14sPn4a-fX7G23_QO4 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB5VRQIuCMJroVAj0XJAC5v1Ors-IFS1VCltcmql3ozXDwgKm6IEUP8Uv5EZ76NJBNx6i-SJ482MZ75Zj78BeIlhw3KDSY40QseZy2WsfZ_jJ-2KRPrEh96Ao_FgeJZ9PBfnG_C7vQtDZZWtTwyO2s4MvSPHJB3T7VQUff7-4ntMXaPodLVtoVGbxbG7_IUp2_zd0QHqdydNDz-c7g_jpqtAbBCdL2JvfZlLp7koy6zk3JvCa20HPNeJsdYah4hJpqnmZqA9N1xatNpBKYX0ORf0AhRd_o2M49akm-n7SyUlIum4qzh1AGpZGBFliKbqPuHF28lXunbYz9-k1KN8KR6uR4WlsLhesrl2bhvC4eFduNPgWLZXG9492HBVD6KDiVuwXdaQjU7ZuOX678HNUXOK34PeFVZF4dBnfX4fPqPFsvpqzU_HQgl904uLzTz75hZortOJYbqyrGa9JcYQpsuKYPc0MMOyxYyhwSOgJUl7OaewHaaY4Cx1D4QHcHYtCnsIm9Wsco-BFQVmv2Uq-76UmbQWZ5E6T_VA2Nwg1I3gdasMZRqOdGrVMVXhrJ4XClWnSHUKVRfBTid9UXOD_ENum_Sq6putnUtRewKxc8YR5UbwKkiQU8HfM7q5G4GrJnquFcmtFUl0BmZ1uLUd1TijubraOhG86Ibpm1RgV7nZj7lCiTxBaJonETyqTa17JszJMenM0gjyFSPsBIiifHWkmnwJVOUCw4MocM7d1lyvlvW3v-rJ_9e_DbeGp6MTdXI0Pn4Kt3GgqOsBt2ATDc89Q4C4KJ-HXcng03W7gT94PXny |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB5VRaq4IAivhUKNRMsBLd2s17F9QKhqqFpKIw5U6s14_YCgsClKAPWv8esYex95CLj1FsUTx8mMZ75Zj78BeI5hw1KDSY40TKeF4zLVvk_xlXYikz7zsTfg2WhwfF68u2AXG_C7vQsTyipbnxgdtZ2a8Iwck3RMt3Mm-nTfN2URH4ZHby6_p6GDVDhpbdtp1CZy6q5-Yfo2e30yRF3v5vnR24-Hx2nTYSA1iNTnqbe-5NJpysqyKCn1Rnit7YBynRlrrXGInmSea2oG2lNDpUULHpSSSc8pCw9D0f3f4JSLsMfE4VJ5Ccs6HisaugG1jIyIOFhTgZ9RsT_-Gq4g9vmrPPQrX4qN6xFiKUSul2-uneHG0Hh0G241mJYc1EZ4BzZc1YNkOHZzskca4tEJGbW8_z3YOmtO9HvQW-BWFI4912d34TNaL6mv2fx0JJbTN325yNSTb26OpjsZG6IrS2oG3MAeQnRZBQg-iSyxZD4laPwIboOkvZqFEB6nGOMsdT-Ee3B-LQq7D5vVtHIPgQiBmXCZy74vZSGtxVmk5rkeMMsNwt4EXrbKUKbhSw9tOyYqnttToVB1KqhOoeoS2O2kL2uekH_I7QS9qvqWa-de1AFDHF1QRLwJvIgSwcHg9xnd3JPAVQeqrhXJ7RVJdAxmdbi1HdU4pplabKMEnnXD4ZOh2K5y0x8zhRI8Q5jKswQe1KbW_SbMzzEBLfIE-IoRdgKBrnx1pBp_ibTlDEMFEzjnXmuui2X97a969P_178AWOgD1_mR0-hhu4vuiLg3chk20O_cEseK8fBo3JYFP1-0F_gAWCH4o |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+relative+contribution+of+metabolic+and+structural+abnormalities+to+diastolic+dysfunction+in+obesity&rft.jtitle=International+Journal+of+Obesity&rft.au=Rayner%2C+J+J&rft.au=Banerjee%2C+R&rft.au=Holloway%2C+C+J&rft.au=Lewis%2C+A+J+M&rft.date=2018-03-01&rft.pub=Nature+Publishing+Group&rft.issn=0307-0565&rft.volume=42&rft.issue=3&rft.spage=441&rft_id=info:doi/10.1038%2Fijo.2017.239&rft.externalDocID=A532643009 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon |